Byline: Dr. jaime T. Galvez Tan
All herbal medicine enthusiasts are invited to join the National Summit on Herbal Medicine on Aug. 14, Thursday to be held at the Philippine General Hospital U.P. Manila Social Hall, 8th Floor from 8 a.m. to 5 p.m.
This is the culmination of the five-month series of the National Colloquium on the State of Medicinal Plants Research and their Business Applications, jointly sponsored by the University of the Philippines Los Banos, Philippine Council for Health Research and Development (PCHRD) of the Department of Science and Technology (DoST), Philippine Institute for Traditional and Alternative Health Care (PITAHC), UP Manila and the National Institutes of Health-Philippines (NIH-P), Center for International Trade Expositions and Missions (CITEM) of the Department of Trade and Industry, (DTI), UP Diliman and the Chamber of Herbal Industries of the Philippines Inc. (CHIPI).
The National Summit of Herbal Medicine will finalize three result areas, namely: the National Research Agenda on Medicinal Plants Research; the National Action Plan for Herbal Medicine and Natural Products Production and Promotion; and the Organization and Management of all Stakeholders in Herbal Medicine.
On the National Research Agenda on Medicinal Plants Research, the research areas will range from the agricultural component to their phytochemistry and pharmaceutical preparations to their standard and regulations to the marketing and trading of medicinal plants. The agricultural component will focus on the following: taxonomy and botanical identification of medicinal plants, their phyto and histochemical contents and finger printing, their propagation and agricultural management, crop protection, harvest and post harvest technology and storage and shelf life of semi-processed raw herbal medicines.
The pharmaceutical and pharmacological components will deal with the following: herbal medicine testing on toxicology, mutagenicity, bioassays, preformulations, dosage formulations, stability studies, ethical issues, animal and human trials, safety and efficacy, quality assurance and control. On the promotion, marketing and trading of herbal medicines, the standards and regulations of the Bureau of Food and Drugs (BFAD) will be the framework, alongside with the Wildlife Act of 2003 which will deal with bioprospecting, patent and intellectual property rights, promotion of the rights and health of indigenous Filipinos, the applications at community level and at commercial level, both for domestic and international markets. …